UK Chemotherapy Board - Good Practice Guideline for Immuno-Oncology Medicines

By Steve Williamson on 24 December 2018

BOPA is pleased to note that the United Kingdom Chemotherapy Board has published  Good Practice Guideline for Immuno-Oncology Medicines which BOPA was a key contributor.  See the RCR’s website.  and BOPA's Partner Organisation Publication Page  
 
Close
Close
Close